Practice
Clinical updates, guidelines, prescribing, and practical medicine
Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing Gut Barrier in Animal Studies
An experimental compound called DT-109 reversed severe fatty liver disease in preclinical animal models by restoring intestinal barrier integrity and…
Editor's Top Picks
Engineered Islet Transplant Survives Without Immunosuppression in First-in-Human Trial
A first-in-human trial published in the New England Journal of Medicine demonstrates long-term survival of genetically engineered pancreatic islet cells…
Submit Your Paper →
More form Practice
UK tightens oversight of high-street health self-tests after BMJ finds safety gaps
The UK's medicines regulator is planning stricter oversight of high-street health self-tests following a BMJ…
FDA Issues Safety Alert Over TRUE METRIX Blood Glucose Monitors: Risk of Inaccurate Readings
The FDA has issued a safety alert regarding TRUE METRIX blood glucose monitoring systems by…
New guidance on advanced therapy clinical trials: What researchers need to know
The Danish Medicines Agency has published new standardized guidance on Investigator's Brochures for advanced therapy…
FDA Issues Correction Notice for TRUE METRIX Blood Glucose Monitors Over Error Code Risk
Trividia Health has issued a correction notice for TRUE METRIX blood glucose monitors after reports…
First-Trimester NSAIDs and Birth Defects: Large Cohort Study Finds No Increased Risk
A population-based cohort study of 54,000 pregnancies found no increased risk of major congenital malformations…